Hydromer Inc. Announces Formation of its Scientific Advisory Board with the Appointment of its First Member Eric Becktel

in Oct 24, 2023

CONCORD, NC, Oct. 24, 2023 — via – Hydromer, Inc (OTC: HYDI), is thrilled to announce the formation of the Company’s first Scientific Advisory Board and proudly introduce its inaugural member, Mr. Eric Becktel. With a rich and diverse background in the dynamic biotech industry, Mr. Becktel brings not only a wealth of experience and[…]

Read more

Hydromer, Inc. Releases Letter to Shareholders from Chairman Braeden Lichti

in Sep 14, 2023

CONCORD, NC, Sept. 14, 2023 (GLOBE NEWSWIRE) — via Hydromer Inc. (OTC: HYDI) (“The Company”), a worldwide supplier of specialty coatings and biopolymers for medical devices and industrial applications, announced today the release of a letter to shareholders from its Executive Chairman, Mr. Braeden Lichti. This letter, which is available for viewing at 2023-002.pdf (hydromer.com), offers an[…]

Read more

Hydromer, Inc. Marks a Formidable Presence: Set to Exhibit at BIOMEDevice Conferences in Boston and Santa Clara

in Aug 25, 2023

Hydromer Inc. (OTC: HYDI) (the “Company”), a worldwide supplier of specialty coatings and biopolymers for medical devices and industrial applications, is pleased to announce its attendance with a booth at both BIOMEDevice Boston being held on September 20-21, 2023, in Boston, MA, and BIOMEDevice Silicon Valley on November 15-16, 2023, Santa Clara, CA. BIOMEDevice conferences bring engineers,[…]

Read more

Hydromer, Inc. Appoints New CEO

in Apr 25, 2023

Concord, NC, April 25, 2023 — Hydromer Inc. (OTC: HYDI), a worldwide supplier of specialty coatings and biopolymers for medical devices and industrial applications, announced today that Mr. Michael E. Torti has been appointed the new Chief Executive Officer of the company. Mr. Torti previously served Hydromer Inc. in the capacity of Vice President of[…]

Read more